Cargando…
Association between multiple sclerosis disease severity and adherence to disease-modifying therapies
BACKGROUND: For multiple sclerosis (MS) patients taking disease-modifying therapies (DMTs), adherence to treatment is a key component of achieving beneficial outcomes, such as delayed disease progression and the reduction and prevention of symptoms and relapses. OBJECTIVES: The aim of this study was...
Autores principales: | Burkhard, Adam, Toliver, Joshua, Rascati, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391086/ https://www.ncbi.nlm.nih.gov/pubmed/34185555 http://dx.doi.org/10.18553/jmcp.2021.27.7.915 |
Ejemplares similares
-
Adherence to Disease-Modifying Therapies for Multiple Sclerosis
por: Higuera, Lucas, et al.
Publicado: (2016) -
Adherence to disease-modifying therapies in patients with multiple sclerosis
por: Kołtuniuk, Aleksandra, et al.
Publicado: (2018) -
Predictors of adherence and persistence to disease-modifying therapies in Multiple Sclerosis
por: Zanga, Gisela, et al.
Publicado: (2021) -
Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis
por: Alosaimi, Fahad D, et al.
Publicado: (2017) -
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
por: Simpson-Yap, Steve, et al.
Publicado: (2021)